Delivery Order SPE2DR25D2101-SPE2DR26F46SS
- Not listed
- The Defense Logistics Agency awarded a $1,546.46 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on December 5, 2025, with completion scheduled for December 8, 2025. This competitively awarded, firm fixed-price contract reflects a small-value pharmaceutical transaction typical of the company's extensive federal medical supply portfolio. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a contract value of $13,532.97. This firm fixed-price delivery order is set to be completed by December 19, 2025, and represents fulfillment under the company's broader pharmaceutical supply relationship with the federal government. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $23,834.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 5 mg on December 2, 2025, with completion scheduled for December 3, 2025. This non-set-aside competitive award represents a pharmaceutical supply delivery to support federal medical procurement needs. The order is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $35,692.53 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 2, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $5,705.01 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on December 19, 2025, with an ultimate completion date of December 22, 2025. This contract utilizes a firm fixed price structure with no set-aside designation, indicating the award was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $6,652.48 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on December 15, 2025, with completion scheduled for December 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's broader pharmaceutical supply framework. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $17,221.27 to AmerisourceBergen Drug Corp for 60-count packages of Eliquis 5 mg tablets, with an ultimate completion date of October 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract valued at $12,867.27, with completion scheduled for December 4, 2025. This non-set-aside competitive award reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract was performed at the company's headquarters location in...
- The Defense Logistics Agency awarded a $8,319.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on November 20, 2025, with an ultimate completion date of November 21, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,469.83 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Eliquis 5 mg tablets in a 60-count package. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The contract is scheduled for ultimate completion on November 18, 2025, with performance of this pharmaceutical delivery occurring at AmerisourceBergen's corporate office location...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46SSDelivery Order
The Defense Logistics Agency awarded a $15,223.68 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on December 19, 2025, with completion scheduled for December 22, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to support federal medical supply requirements. The order will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, holds significant federal contracting capacity and regularly fulfills competitively awarded delivery orders for specialty medications and brand-name drugs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.2k | 12/18/25 |